The brokerage has chosen its healthcare stocks Narayana Hrudayalaya (NSE: NH) for short-term investors who plan to make a bet in a couple of months. The stock closed at Rs 1217 last week.
It is recommended to hold this stock for at least a couple of months. It provides affordable healthcare to people. It also offers multi-specialty and super-specialty hospitals.
Narayana Hrudayalaya Share Price Target
A top brokerage firm has selected this healthcare stock for investors who are looking to invest in the short term. The shares are trading at 1217 rupees.
Brokerage has suggested buying it in the price range of Rs 1215 up to Rs 1200. For the next 3 months, a target of Rs 1358 as well as the stop loss amount of 1139 rupees was advised.
Brokerage Advise
According to its annual report, the brokerage stated that the stock has generated solid support at Rs 1150. The stock has retreated from the support levels.
The range from 1150 to 1210 is one of consolidation. The stock has shown an opportunity to break out with a volume.
The monthly and weekly charts show a bullish trend for the near future. The technical structure is positive.
Narayana Hrudayalaya Share Price History
Narayana Hrudayalaya Share closed at the price of Rs 1217. The 52-week peak is 1314, which is the all-time high. The 52-week low is Rs 705.
The market capitalization for the company is 24,880 crore. The stock increased this week in value by 1.3 percent.
In one month, the returns were unchanged. This stock has delivered an annual return of 12 percent over three months, and 68 percent over one year.
About Narayana Hrudayalaya Ltd
Narayana Hrudayalaya Ltd is an India-based healthcare service provider in Bengaluru. It is a public corporation founded on the 19th of July 2000.
This company’s growth has been phenomenal, from its initial location to 21 facilities, six heart centers along with 19 basic care centers in India in addition to an international hospital located in the Cayman Islands.
It offers the latest medical treatments across a variety of specialties comprising Cardiology and cancer Care, Neurology, Orthopaedics, Nephrology, and Gastroenterology.
Narayana Hrudayalaya has an impressive financial record and plans to provide long-term value for its shareholders.
It aims to offer the highest-quality, affordable health care for all of the population.
The company’s focus is on efficiency, creativity, and compassion, as well as accountability as well as respect and excellence.
Fundamental Analysis of Narayana Hrudayalaya Ltd
| Market Cap | ₹ 24,880 Cr. |
| Current Price | ₹ 1,212.30 |
| 52-wk High | ₹ 1,314.10 |
| 52-wk Low | ₹ 705.10 |
| Stock P/E | 33.38 |
| Book Value | ₹ 122 |
| Dividend | 0.21 % |
| ROCE | 31.6 % |
| ROE | 33.1 % |
| Face Value | ₹ 10.0 |
| P/B Value | 9.95 |
| OPM | 22.7 % |
| EPS | ₹ 36.1 |
| Debt | ₹ 1,072 Cr. |
| Debt to Equity | 0.43 |
Narayana Hrudayalaya Ltd Shareholding Pattern
| Promoters Holding | |
| Sept 2022 | 63.85% |
| Dec 2022 | 63.85% |
| Mar 2023 | 63.85% |
| June 2023 | 63.85% |
| Sept 2023 | 63.85% |
| FII Holding | |
| Sept 2022 | 9.55% |
| Dec 2022 | 10.24% |
| Mar 2023 | 10.36% |
| June 2023 | 11.10% |
| Sept 2023 | 11.59% |
| DII Holding | |
| Sept 2022 | 16.62% |
| Dec 2022 | 14.58% |
| Mar 2023 | 14.14% |
| June 2023 | 11.95% |
| Sept 2023 | 10.89% |
| Public Holding | |
| Sept 2022 | 9.28% |
| Dec 2022 | 10.70% |
| Mar 2023 | 11.01% |
| June 2023 | 12.45% |
| Sept 2023 | 13.05% |
| Others | |
| Sept 2022 | 0.69% |
| Dec 2022 | 0.63% |
| Mar 2023 | 0.63% |
| June 2023 | 0.63% |
| Sept 2023 | 0.62% |
Narayana Hrudayalaya Ltd Share: Last 5 Years’ Financial Condition
To gain a better understanding of how the market is performing, let’s look at the outlook of this share in the previous years.
However, investors should be aware of the risks and the market conditions before making any investment decision.
Last 5 Years’ Sales:
| 2019 | ₹ 2,861 Cr |
| 2020 | ₹ 3,128 Cr |
| 2021 | ₹ 2,583 Cr |
| 2022 | ₹ 3,701 Cr |
| 2023 | ₹ 4,888 Cr |
Last 5 Years’ Net Profit:
| 2019 | ₹ 59 Cr |
| 2020 | ₹ 119 Cr |
| 2021 | ₹ -14 Cr |
| 2022 | ₹ 342 Cr |
| 2023 | ₹ 738 Cr |
Last 5 Years’ Debt-To-Equity Ratio:
| 2019 | 0.68 |
| 2020 | 0.55 |
| 2021 | 0.47 |
| 2022 | 0.37 |
| 2023 | 0.36 |
Last 10 Years’ Profit Growth:
| 10 Years: | 49% |
| 5 Years: | 63% |
| 3 Years: | 67% |
| Current Year: | 65% |
Last 10 years’ Return on Equity (ROE):
| 10 Years: | 12% |
| 5 Years: | 18% |
| 3 Years: | 22% |
| Last Year: | 33% |
Sales Growth Over 10 Years:
| 10 Years: | 18% |
| 5 Years: | 15% |
| 3 Years: | 13% |
| Current Year: | 20% |
Conclusion
This article is a complete guide about Narayana Hrudayalaya Ltd Share.
These information and forecasts are based on our analysis, research, company fundamentals and history, experiences, and various technical analyses.
Also, We have talked in detail about the share’s future prospects and growth potential.
Hopefully, these informations will help you in your further investment.
If you are new to our website and want to get all the latest updates related to the stock market, join us on Telegram Group.
If you have any further queries, please comment below. We will be happy to answer all your questions.
If you like this information, share the article with as many people as possible.
Also Read: 15,581% Return Renewable Energy Stocks Hit Upper Circuit After Stock Split News
Disclaimer: Dear readers, we’d like to inform you that we are not authorized by SEBI (Securities and Exchange Board of India). The information on this site is only for informational and educational purposes and shouldn’t be considered financial advice or stock recommendations. Also, the share price predictions are completely for reference purposes. The price predictions will only be valid when there are positive signs on the market. Any uncertainty about the company’s future or the current state of the market will not be considered in this study. We are not responsible for any financial loss you might incur through the information on this site. We are here to provide timely updates about the stock market and financial products to help you make better investment choices. Do your own research before any investment.
